Dozens of Actos lawsuits against drugmaker Takeda Pharmaceuticals have been filed by patients who allege that the drug caused them to develop bladder cancer. According to lawyers involved in the Actos litigation, thousands of additional patients have already contacted an attorney to discuss whether they are eligible to file a case.
Researchers analyzing the side effects of Actos have found that patients who use the diabetes drug for more than 12 months face a 40% increased risk of being diagnosed with bladder cancer. Studies show that patients prescribed high doses of Actos were 75% more likely to receive a bladder cancer diagnosis.
A 2012 study appearing in the British Medical Journal analyzed 115,000 diabetes patients and determined that taking Actos for more than two years can double a patient’s risk of developing bladder cancer.
Evidence linking Actos and bladder cancer has prompted health officials in France and Germany to restrict sales of the drug in those countries. Although the Food and Drug Administration warned about a possible increased risk of bladder cancer from taking the drug, the agency has not announced plans to issue an Actos recall.
In addition to the dozens of individual lawsuits filed against Takeda, the company is also facing an Actos class action lawsuit filed by on behalf of former patients. The lawsuit is seeking a settlement to cover medical monitoring in order to detect bladder cancer symptoms among former Actos users.
If you or a loved one used Actos and were diagnosed with bladder cancer, you may qualify to file a lawsuit. To get a free legal consultation and find out if you are eligible, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.